A Phase III Trial of Paclitaxel plus Carboplatin Versus Paclitaxel plus Cisplatin in Stage IVB, Persistent or Recurrent Cervical Cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)

I. Saito; R. Kitagawa; H. Fukuda; T. Shibata; N. Katsumata; I. Konishi; H. Yoshikawa; T. Kamura

doi:10.1093/jjco/hyp117

A Phase III Trial of Paclitaxel plus Carboplatin Versus Paclitaxel plus Cisplatin in Stage IVB, Persistent or Recurrent Cervical Cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyp117 ◽

2009 ◽

Vol 40 (1) ◽

pp. 90-93 ◽

Cited By ~ 34

Author(s):

I. Saito ◽

R. Kitagawa ◽

H. Fukuda ◽

T. Shibata ◽

N. Katsumata ◽

...

Keyword(s):

Gynecologic Cancer ◽

Phase Iii ◽

Study Group ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Recurrent Cervical Cancer ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Cancer Study Group ◽

Stage Ivb

Download Full-text

A Randomized Phase III Trial of Paclitaxel Plus Carboplatin (TC) Versus Paclitaxel Plus Cisplatin (TP) in Stage IVB or Recurrent Cervical Cancer: Japan Clinical Oncology Group Study (JCOG0505)

Annals of Oncology ◽

10.1016/s0923-7534(20)32358-9 ◽

2012 ◽

Vol 23 ◽

pp. xi126 ◽

Cited By ~ 1

Author(s):

R. Kitagawa ◽

N. Katsumata ◽

T. Shibata ◽

T. Nakanishi ◽

S. Nishimura ◽

...

Keyword(s):

Cervical Cancer ◽

Clinical Oncology ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Recurrent Cervical Cancer ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Stage Ivb

Download Full-text

A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyy004 ◽

2018 ◽

Vol 48 (4) ◽

pp. 392-395 ◽

Cited By ~ 25

Author(s):

Kohei Nakachi ◽

Masaru Konishi ◽

Masafumi Ikeda ◽

Junki Mizusawa ◽

Junko Eba ◽

...

Keyword(s):

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Tract Cancer

Download Full-text

A randomized controlled Phase III trial comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF) with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal cancer: rationale, design and methods of Japan Clinical Oncology Group study JCOG1314 (MIRACLE study)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyv012 ◽

2015 ◽

Vol 45 (5) ◽

pp. 494-498 ◽

Cited By ~ 12

Author(s):

K. Kataoka ◽

T. Tsushima ◽

J. Mizusawa ◽

S. Hironaka ◽

Y. Tsubosa ◽

...

Keyword(s):

Esophageal Cancer ◽

Clinical Oncology ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Weekly Docetaxel ◽

Randomized Controlled ◽

Design And Methods

Download Full-text

A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyv178 ◽

2016 ◽

Vol 46 (2) ◽

pp. 174-177 ◽

Cited By ~ 32

Author(s):

Kozo Kataoka ◽

Hiroya Takeuchi ◽

Junki Mizusawa ◽

Masahiko Ando ◽

Yasuhiro Tsubosa ◽

...

Keyword(s):

Esophageal Cancer ◽

Clinical Oncology ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Thoracic Esophageal Cancer ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Open Esophagectomy

Download Full-text

A cohort study of gastric-type adenocarcinoma (GAS) of the uterine cervix: Multi-institutional study by Gynecologic Cancer Study Group of the Japan Clinical Oncology Group (JCOG).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.5595 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 5595-5595

Author(s):

Shin Nishio ◽

Yoshiki Mikami ◽

Takeo Otsuki ◽

Nobuo Yegashi ◽

Toyomi Satoh ◽

...

Keyword(s):

Cohort Study ◽

Clinical Oncology ◽

Uterine Cervix ◽

Gynecologic Cancer ◽

Study Group ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Cancer Study ◽

Cancer Study Group ◽

Gastric Type

Download Full-text

Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyx063 ◽

2017 ◽

Vol 47 (7) ◽

pp. 664-667 ◽

Cited By ~ 8

Author(s):

Kenjiro Namikawa ◽

Arata Tsutsumida ◽

Tomonori Mizutani ◽

Taro Shibata ◽

Tatsuya Takenouchi ◽

...

Keyword(s):

Adjuvant Therapy ◽

Clinical Oncology ◽

Cutaneous Melanoma ◽

Interferon Beta ◽

Stage Ii ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study

Download Full-text

The History of the Gynecologic Cancer Study Group (GCSG) of the Japan Clinical Oncology Group (JCOG)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyr111 ◽

2011 ◽

Vol 41 (10) ◽

pp. 1156-1161

Author(s):

T. Onda ◽

I. Konishi ◽

H. Yoshikawa ◽

T. Kamura

Keyword(s):

Clinical Oncology ◽

Gynecologic Cancer ◽

Study Group ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Cancer Study ◽

Cancer Study Group ◽

History Of

Download Full-text

Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-016-3133-4 ◽

2016 ◽

Vol 78 (4) ◽

pp. 785-790 ◽

Cited By ~ 3

Author(s):

Shin Nishio ◽

Ryo Kitagawa ◽

Taro Shibata ◽

Hiroyuki Yoshikawa ◽

Ikuo Konishi ◽

...

Keyword(s):

Cervical Cancer ◽

Prognostic Factors ◽

Clinical Oncology ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Recurrent Cervical Cancer ◽

Phase Iii Trial

Download Full-text

A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical Oncology Group Study JCOG1408 (J-SBRT trial)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyw198 ◽

2017 ◽

Cited By ~ 4

Author(s):

Tomoki Kimura ◽

Yasushi Nagata ◽

Junko Eba ◽

Shuichi Ozawa ◽

Satoshi Ishikura ◽

...

Keyword(s):

Lung Cancer ◽

Primary Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Japan Clinical Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Stage Ia

Download Full-text

Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer: Japan Clinical Oncology Group study (JCOG0501).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.4046 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 4046-4046 ◽

Cited By ~ 21

Author(s):

Yoshiaki Iwasaki ◽

Masanori Terashima ◽

Junki Mizusawa ◽

Hiroshi Katayama ◽

Kenichi Nakamura ◽

...

Keyword(s):

Gastric Cancer ◽

Clinical Oncology ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Large Type ◽

Type 3

Download Full-text